2008
DOI: 10.1016/j.jpedsurg.2007.09.049
|View full text |Cite
|
Sign up to set email alerts
|

Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
51
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 62 publications
(52 citation statements)
references
References 9 publications
(25 reference statements)
1
51
0
Order By: Relevance
“…Other authors also report good results without complications using ethanol and sodium tetradecyl sulfate 3% to enhance the intralesional effects of ethanol [36,37].…”
Section: Discussionmentioning
confidence: 91%
“…Other authors also report good results without complications using ethanol and sodium tetradecyl sulfate 3% to enhance the intralesional effects of ethanol [36,37].…”
Section: Discussionmentioning
confidence: 91%
“…Surgery is the preferred first-line management although microcystic LMs recur in 40% of patients with incomplete excision and in 17% of patients with complete resection. 104 Sclerotherapy is typically ineffective in treating microcystic LMs, although positive treatment outcomes have been reported with doxycycline, 105 bleomycin 91 and OK-432. 106 In addition, an intermediate response in 50% of cases has also been observed.…”
Section: Lymphatic Malformationsmentioning
confidence: 99%
“…Sclerosing agents are left within the cyst for a variable amount of time depending on which agent is used and, typically, multiple treatments of injection and drainage are required (Figure 6e). 94,105 For large lesions with multiple cysts, the catheter is often secured in place, injecting and draining cysts sequentially for several days.…”
Section: Lymphatic Malformationsmentioning
confidence: 99%
“…Doxycycline is an antibiotic that heals microcystic and macrocystic lymphatic malformations that are associated with elevated VEGF and MMPs [6,29,39,40]. In bone and soft tissue malignancy cell cultures, doxycycline demonstrates antitumoral properties with inhibition of MMP and angiogenesis [12,13,15], inhibition of osteoclastic function, and induction of osteoclastic apoptosis [12,13,15,19].…”
mentioning
confidence: 99%